TeleMedical Genetics 6-month Professional Program and Practice Blueprint
A comprehensive 24-week professional development program designed for clinicians, genetic counselors, healthcare providers, and practice owners who want to launch or scale telegenetics services. This cohort-based curriculum combines live virtual sessions with asynchronous learning, hands-on labs, and practice development, culminating in a capstone project that prepares participants to operate a compliant, revenue-generating telegenetics clinic aligned with industry standards and regulations.
6-Month Curriculum Overview
The program consists of 120 carefully sequenced learning modules delivered over 24 weeks, beginning with orientation and foundations and progressing through specialized clinical applications, compliance frameworks, technology implementation, and business development.
Weeks 2-3: Telehealth Basics and Genetics Fundamentals
- Clinical Workflows in Telehealth — Master the essential components of virtual care delivery, including appointment scheduling, documentation, and follow-up protocols.
- Patient Selection and Digital Inclusion — Identify appropriate candidates for telegenetics services while addressing technology barriers and accessibility needs.
- Tele-triage and Red-flag Escalation — Develop systems to appropriately screen patients and recognize situations requiring urgent in-person assessment.
- Tele-consent and Documentation — Implement legally sound electronic consent processes and documentation practices for virtual genetic services.
- Managing Emergencies Remotely — Establish protocols for handling clinical emergencies and maintaining duty-of-care in telehealth settings.
- Mendelian Inheritance and Penetrance — Review classic inheritance patterns and the concept of variable penetrance in genetic conditions.
- Polygenic Risk and Complex Traits — Explore multifactorial inheritance and the clinical application of polygenic risk scores.
- Gene-Environment Interactions — Understand how environmental factors influence gene expression through epigenetic mechanisms.
- Variant Types and Mechanisms — Classify genetic variants and their potential functional impacts on protein synthesis and function.
- Population Genetics Considerations — Apply principles of population genetics and ancestry in test selection and interpretation.
Weeks 4-6: Advanced Genetics and Testing Modalities
Building on the foundation established in Week 3, participants will develop practical skills in family history assessment, hereditary risk identification, and complex genetic concepts including genotype-phenotype correlations and variant of uncertain significance (VUS) management. Cultural competency and effective risk communication strategies round out this critical module.
- Family History & Pedigree Building: Techniques for collecting and documenting 3-4 generation family histories
- Hereditary Red Flags: Identifying patterns suggestive of genetic conditions
- Genotype-Phenotype Correlations: Understanding relationships between genetic variants and clinical presentations
- Genetic Heterogeneity & VUS Management: Approaches to cases with unclear genetic findings
- Cultural Humility & Risk Communication: Culturally sensitive approaches to discussing genetic risk
- Cytogenetic & Microarray Analysis — Karyotype, FISH, and chromosomal microarray techniques for detecting large structural variants and copy number changes.
- Targeted & Panel Testing — Single-gene analysis and multi-gene panels for specific clinical indications, with considerations for test selection.
- Comprehensive Genomic Analysis — Whole-exome sequencing (WES) and whole-genome sequencing (WGS) applications, benefits, and limitations.
- Pharmacogenomics & Specialty Testing — PGx testing for medication response, tumor profiling, carrier screening, prenatal testing, and newborn screening protocols.
By the end of Week 6, participants will have developed comprehensive knowledge of genetic testing modalities, their clinical applications, and appropriate test selection criteria for various patient scenarios.
Weeks 7-9: Laboratory Operations and Clinical Skills
Understanding the laboratory side of genetic testing is crucial for telegenetics providers. This module covers regulatory requirements, sample logistics for at-home collection, specimen handling protocols, turnaround time expectations, and report interpretation. Key topics include:
- CLIA/CAP laboratory accreditation standards and requirements
- Remote sample collection logistics for saliva and buccal specimens
- Chain of custody protocols and specimen stability considerations
- Service-level agreements and turnaround time management
- Laboratory report structure and identification of critical values
Accurate variant interpretation is the cornerstone of genetic counseling. Participants will learn standardized classification frameworks, database utilization, computational tools, and literature evaluation methods to assess genetic variants. The module also covers reclassification policies and patient recontacting procedures when variant interpretations change over time.
Translating complex genetic information into understandable guidance requires specialized communication skills. This week focuses on virtual counseling techniques, from pretest education through results delivery, with emphasis on psychosocial assessment, family communication, and accessibility considerations for diverse patient populations.
Practice Element: During these weeks, participants will practice sample collection logistics, variant classification exercises, and simulated counseling sessions through role-play with standardized patients to develop critical skills for telegenetics practice.
Weeks 10-12: Clinical Specialties in Genetics
- Cancer genetic testing indications
- NCCN-aligned panel selection
- Risk management counseling
- Virtual tumor boards and second opinions
- Survivorship and fertility considerations
- Channelopathies (LQTS, Brugada, CPVT)
- Cardiomyopathies (HCM, DCM, ARVC)
- Aortopathies and connective tissue disorders
- Familial hypercholesterolemia
- Remote monitoring for cardiac phenotyping
- Epilepsies and neurodevelopmental syndromes
- Movement disorders (Huntington, dystonia)
- Neuromuscular disorders (DMD/SMA/CMT)
- Inborn errors of metabolism
- Newborn screening follow-up models
Evidence-Based Guidelines — Current practice standards from professional organizations like NCCN, ACMG, and specialty societies guide clinical decision-making.
Test Selection Criteria — Detailed frameworks for choosing appropriate genetic testing based on family history, personal medical history, and clinical presentation.
Risk Assessment Models — Validated tools for quantifying genetic risk and determining testing thresholds across different clinical scenarios.
Management Protocols — Condition-specific surveillance and intervention recommendations based on genetic test results and clinical context.
Virtual Care Considerations — Special adaptations required for telehealth delivery of these specialized genetic services, including coordination with local providers.
Weeks 13-15: Reproductive Genetics and Pharmacogenomics
Master the complexities of genetic counseling throughout the reproductive journey, from preconception carrier screening through pregnancy management and loss evaluation.
- Preconception counseling and carrier matching protocols
- Distinguishing between screening and diagnostic prenatal tests
- Teratogen risk assessment and resource utilization
- Genetic evaluation of pregnancy loss
- Ethical frameworks for prenatal decision-making discussions
Develop expertise in comprehensive genetic evaluation strategies for undiagnosed and rare conditions across the lifespan.
- Implementing exome-first diagnostic approaches
- Coordinating trio testing workflows for pediatric cases
- Establishing virtual undiagnosed disease review boards
- Facilitating care coordination with subspecialists
- Managing transition from pediatric to adult genetic services
Integrate personalized medication management based on genetic variants affecting drug metabolism and response.
- Applying CPIC guidelines for clinical implementation
- Interpreting key gene-drug interactions (CYP2D6, CYP2C19, SLCO1B1, HLA)
- Configuring EHR clinical decision support alerts
- Specialty applications in psychiatry, cardiology, oncology, and pain management
- Navigating PGx panel selection and insurance coverage challenges
These specialized modules address complex areas of genetic medicine that require integration with multiple clinical specialties. Participants will learn to:
- Navigate sensitive patient discussions around reproductive choices and rare disease diagnoses
- Develop collaborative care models with maternal-fetal medicine, pediatrics, neurology, and pharmacy
- Create patient-friendly educational materials for complex genetic concepts
- Implement telehealth workflows that accommodate the unique needs of these patient populations
- Establish appropriate documentation and billing practices for these specialized services
Weeks 16-18: Precision Oncology and Regulatory Compliance
Germline vs. Somatic Testing — Understanding the distinct implications of inherited versus tumor-specific genetic alterations and appropriate testing strategies for each.
Tumor-Agnostic Biomarkers — Implementing testing for actionable biomarkers that guide treatment regardless of cancer type, such as MSI-high status and NTRK fusions.
Virtual Molecular Tumor Boards — Establishing and participating in multidisciplinary discussions of complex cancer genomic findings via telehealth platforms.
Clinical Trial Matching — Developing systems to identify appropriate precision oncology trials based on genomic findings and facilitate referrals.
Companion Diagnostics — Navigating FDA-approved companion diagnostic testing requirements for targeted therapies and associated insurance authorization processes.
- HIPAA Privacy Rule implementation in telehealth
- Security Rule safeguards (administrative, physical, technical)
- HITECH breach notification procedures and BAAs
- ONC Cures Act Information Blocking compliance
- State-specific privacy requirements and 42 CFR Part 2
- Telehealth-specific fraud, waste, and abuse risk areas
- Stark Law and Anti-Kickback Statute applications
- OSHA compliance for remote and small-office settings
- Documentation standards for telehealth billing
- Audit preparation and incident response protocols
Compliance Alert: Telegenetics services face heightened scrutiny in regulatory audits. These modules provide essential knowledge to establish proper safeguards and avoid costly violations that could disrupt practice operations.
Week 19: Health IT Stack and Interoperability
- EHR Selection for Telegenetics — Evaluate electronic health record systems based on genetics-specific functionality, telehealth integration capabilities, template customization, and cost-effectiveness for small to mid-sized practices.
- Laboratory Interfaces and Standards — Implement FHIR/HL7 interfaces for seamless lab order and results transmission, with proper LOINC/SNOMED coding to ensure structured genetic data capture and interoperability.
- Digital Patient Engagement Tools — Deploy integrated solutions for electronic consent, identity verification, electronic signatures, family history collection, and secure pre-visit questionnaires to streamline workflow.
- Secure Communication Infrastructure — Establish HIPAA-compliant video conferencing, messaging, and data storage systems with appropriate access controls, encryption, and audit capabilities.
- Analytics and Quality Measurement — Configure dashboards to track key performance indicators, patient outcomes, and quality metrics specific to telegenetics services for continuous improvement.
- Conducting technology needs assessments based on practice size and specialty focus
- Managing vendor selection and contract negotiation processes
- Creating implementation timelines and staff training plans
- Establishing policies for technology maintenance and updates
- Developing contingency plans for technology failures during patient care
This module provides hands-on experience with sample platforms through lab exercises, allowing participants to practice configuring telehealth systems, EHR templates, and laboratory interfaces in a safe environment before implementing in their own practices.
Weeks 20-22: Practice Management and Business Development
This module covers the foundational elements of establishing a telegenetics practice, including legal structure, licensing considerations for interstate practice, credentialing processes, and operational workflows.
- Entity Formation and Licensure — Selecting appropriate business structures and navigating multistate licensing requirements and interstate compacts.
- Credentialing and Enrollment — Streamlining provider credentialing, payer enrollment, and CAQH profile management for telehealth services.
- Service Pricing Models — Developing cash-pay options, payer fee schedules, and bundled service packages with competitive market positioning.
- Scheduling Optimization — Creating efficient appointment templates and managing patient flow to maximize provider productivity.
- Policy Development — Establishing standard operating procedures, clinical protocols, and comprehensive risk management strategies.
Revenue Cycle Management (Week 21)
- Telehealth billing codes (E/M, modifier 95, POS 02/10)
- Genetics-specific coding (test CPTs, Z-codes)
- Prior authorization and medical necessity documentation
- Denial management and appeals processes
- Financial forecasting and breakeven analysis
Patient Acquisition Strategy (Week 22)
- Compliant digital marketing for healthcare services
- Building referral networks and provider education
- Patient education programs and conversion funnels
- Accessibility initiatives and community partnerships
- Patient satisfaction measurement and service recovery
Business Performance Metrics — New Patient Visits per..., Follow-up Conversion Rate, Genetic Test..., Days in A/R, Patient Satisfaction...
Genetic testing provides powerful insights, but optimal patient outcomes often require complementary approaches that address modifiable factors. This module presents evidence-aligned adjunctive strategies that telegenetics providers can incorporate into patient care plans.
Important Disclaimer: Holistic modalities are adjuncts designed to complement, not replace, medically indicated diagnostics or treatments. Providers should maintain clear scope boundaries and avoid making unsupported claims about alternative approaches.
Evidence-based dietary patterns (Mediterranean, DASH), physical activity prescriptions, sleep optimization protocols, tobacco cessation, and alcohol moderation strategies.
Mindfulness-based stress reduction techniques, cognitive behavioral therapy approaches, therapeutic yoga, breathing exercises, and CBT-I for insomnia management.
Condition-specific nutritional interventions with scientific support, such as folate supplementation during pregnancy, vitamin D for documented deficiency, and omega-3 fatty acids for hypertriglyceridemia.
Complementary approaches for symptom management, including acupuncture for chemotherapy-induced nausea, pelvic floor therapy, genetics-informed nutrition counseling, and pain self-management programs.
Genetic condition-specific peer groups, social work referrals, financial navigation services, and community resource connections to address social determinants of health.
Implementation in Telegenetics Practice — Evidence-based screening tools to identify candidates for complementary interventions; telehealth-compatible resources and digital tools for patient self-management; virtual referral networks for specialized integrative services; documentation templates that appropriately incorporate holistic recommendations; clear communication frameworks that distinguish between established medical recommendations and complementary approaches.
Popular Telegenetics Services You Can Offer
Service Models and Clinical Applications — Upon completion of the program, graduates will be equipped to establish various specialized telegenetics services designed to meet specific patient needs and market demands. These service models can be implemented as standalone offerings or combined to create a comprehensive telegenetics practice.
Risk assessment, genetic testing, and cascade screening for families with cancer predisposition syndromes. Includes results interpretation, management recommendations, and coordination with oncology providers.
Specialized genetic evaluation for inherited cardiac conditions, with remote cascade screening protocols and integration with cardiology practices for comprehensive management.
Personalized medication management consultations focused on psychiatric medications, cardiovascular drugs, pain management, and cancer therapeutics based on genetic profile.
Preconception carrier screening, prenatal testing navigation, and genetic counseling for prospective and expectant parents, with clear referral pathways for diagnostic procedures.
Specialized evaluation and care coordination for children with suspected genetic neurological conditions, including exome sequencing interpretation and multidisciplinary care planning.
Expert second opinion service for tumor genomic profiling interpretation, targeted therapy recommendations, and clinical trial matching for patients with advanced cancers.
Comprehensive genomic evaluation service for complex, previously undiagnosed conditions, featuring virtual case review boards and coordinated diagnostic strategies.
B2B services including employer genetic benefit management, primary care genetics consultation lines, and health system integration programs.
The program provides detailed implementation blueprints for each service model, including workflow diagrams, documentation templates, marketing materials, and revenue projections to facilitate rapid deployment following program completion.
Clinical Note: Telegenetics supports risk assessment, test coordination, and counseling; definitive diagnosis may require in-person examination, procedures, or imaging in some cases. Service design should include appropriate referral mechanisms for these situations.
Hereditary Cancer and Cardiogenetics Conditions
- Hereditary Breast and Ovarian Cancer — BRCA1/2-related cancers and moderate-risk genes including PALB2, CHEK2, and ATM, with risk-appropriate screening and preventive options.
- Lynch Syndrome and Polyposis — MLH1, MSH2, MSH6, PMS2, EPCAM mutations (Lynch); APC and MUTYH variants (polyposis) with colorectal and extracolonic cancer risks.
- Multi-Cancer Predisposition — Li-Fraumeni (TP53), Cowden (PTEN), Peutz-Jeghers (STK11), and hereditary diffuse gastric cancer (CDH1) syndromes requiring comprehensive surveillance.
- Endocrine and Neuroendocrine Tumors — Paraganglioma/pheochromocytoma (SDHx), MEN1/MEN2, VHL, and neurofibromatosis (NF1/NF2) with complex management needs.
- Arrhythmia Syndromes — Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), and other channelopathies affecting cardiac conduction.
- Cardiomyopathies — Hypertrophic, dilated, restrictive, and arrhythmogenic cardiomyopathies with varying genetic etiologies and phenotypic expression.
- Aortopathies — Marfan syndrome (FBN1), Loeys-Dietz syndrome (TGFBR1/2), vascular Ehlers-Danlos (COL3A1), and familial thoracic aortic aneurysm/dissection.
- Lipid Disorders — Familial hypercholesterolemia (LDLR/APOB/PCSK9) and other inherited dyslipidemias affecting cardiovascular risk profiles.
These condition categories represent core areas where telegenetics services can provide significant clinical value through risk assessment, genetic testing, family screening, and management guidance. The program provides detailed modules on each condition group, including testing algorithms, management guidelines, and telehealth-specific implementation considerations.
Neurogenetic, Neuromuscular and Metabolic Conditions
- Trinucleotide Repeat Disorders — Huntington disease and Fragile X syndrome, characterized by expanding nucleotide repeats with complex inheritance patterns and neurological manifestations.
- Neurodevelopmental Syndromes — Tuberous sclerosis, Rett syndrome, and Angelman/Prader-Willi syndromes affecting brain development with multisystem involvement.
- Progressive Neuromuscular Conditions — Charcot-Marie-Tooth, muscular dystrophies, spinal muscular atrophy, and myotonic dystrophy requiring comprehensive management strategies.
- Neurodegeneration and Movement — Hereditary ataxias, Wilson disease, and genetic forms of ALS with variable age of onset and progression trajectories.
- Epilepsy Genetics — Single-gene epilepsy syndromes involving sodium and potassium channels (SCN1A/2A, KCNQ2) and other pathways affecting neuronal excitability.
- Tumor Predisposition Syndromes — Neurofibromatosis 1/2 and schwannomatosis with CNS and peripheral nervous system tumor risks requiring surveillance.
- Amino Acid Disorders — Phenylketonuria, maple syrup urine disease, and homocystinuria affecting protein metabolism with potential for severe neurological complications if untreated.
- Urea Cycle Defects — OTC, ASS1, and ASL deficiencies disrupting ammonia detoxification with risk for hyperammonemia and encephalopathy requiring careful management.
- Fatty Acid Oxidation Disorders — MCAD, VLCAD, and LCHAD deficiencies affecting energy metabolism with risk for hypoglycemia, cardiomyopathy, and other complications during metabolic stress.
- Mitochondrial Disorders — POLG-related conditions and mitochondrial DNA variants causing energy production defects with multisystem involvement and heterogeneous presentation.
- Lysosomal Storage Diseases — Gaucher, Taylor-Sachs, Niemann-Pick, and Krabbe disease characterized by enzyme deficiencies leading to substrate accumulation and progressive cellular dysfunction.
Telegenetics services for these complex conditions focus on test selection, results interpretation, and coordination with local specialists for ongoing management. The program provides detailed protocols for multidisciplinary collaboration in these cases.
Hematology, Immunology, Endocrine and Connective Tissue Disorders
- Hemochromatosis (HFE): Iron overload disorder with simple genetic testing but complex penetrance considerations
- Hemoglobinopathies: Alpha/beta-thalassemia and sickle cell disease requiring comprehensive counseling about reproductive risks and clinical management
- G6PD Deficiency: X-linked enzyme deficiency with medication and dietary triggers requiring personalized avoidance guidance
- Primary Immunodeficiencies: Severe combined immunodeficiency (SCID), common variable immunodeficiency (CVID), and chronic granulomatous disease (CGD) with complex management needs
- Hereditary Angioedema: SERPING1 mutations affecting complement regulation with implications for emergency treatment protocols
- Thrombophilias: Factor V Leiden and prothrombin gene variants with nuanced risk assessment and management considerations
- Monogenic Diabetes: MODY subtypes and neonatal diabetes with implications for treatment selection and family screening
- Adrenal Disorders: Congenital adrenal hyperplasia and disorders of sex development requiring sensitive counseling approaches
- Multiple Endocrine Neoplasia: MEN1 and MEN2 syndromes with complex surveillance requirements across multiple organ systems
- Polycystic Kidney Disease: PKD1/2-related autosomal dominant polycystic kidney disease requiring long-term monitoring
- Inherited Nephropathies: Alport syndrome and salt-wasting disorders (Bartter/Gitelman) with implications for renal management
- Ehlers-Danlos Spectrum — Varied subtypes affecting collagen and connective tissue, ranging from hypermobility to life-threatening vascular complications, requiring multidisciplinary management.
- Osteogenesis Imperfecta — Brittle bone disease with varying severity based on specific collagen mutations, requiring coordinated care with orthopedics, physical therapy, and pain management.
- Genodermatoses — Xeroderma pigmentosum with extreme UV sensitivity and cancer risk; epidermolysis bullosa affecting skin integrity with varying severity and management approaches.
- Hemochromatosis-Related Manifestations — Counseling regarding skin findings associated with hereditary hemochromatosis, including bronze discoloration, and their relationship to iron overload status.
These diverse conditions present unique telegenetic counseling challenges and opportunities. The program provides specialized modules on developing cultural competency, addressing health literacy barriers, and creating accessible telehealth services for patients with these genetic conditions.
Ophthalmologic, Otolaryngology, and Reproductive Genetics
- Retinitis Pigmentosa: Progressive retinal degeneration with genetic heterogeneity
- Stargardt Disease: Macular degeneration with childhood or early adult onset
- Leber Congenital Amaurosis: Severe visual impairment from birth
- Usher Syndrome: Combined hearing and vision loss with variable onset
- GJB2/6-Related Hearing Loss: Common cause of congenital deafness
- Waardenburg Syndrome: Hearing loss with pigmentary abnormalities
- Usher Syndrome: Progressive hearing and vision loss
- Syndromic Hearing Loss: Multiple gene panels for complex presentations
- Carrier Screening: Cystic fibrosis, SMA, Fragile X premutation
- Hemoglobinopathy Screening: Sickle cell, thalassemias
- NIPS Counseling: Interpretation of non-invasive prenatal screening
- Recurrent Pregnancy Loss: Genetic factors including translocations
Pharmacogenomic Applications
Pharmacogenomics (PGx) identifies genetic variations that influence medication response, allowing for personalized prescribing that can improve efficacy and reduce adverse effects. Key actionable gene-drug pairs covered in the program include:
- CYP2D6 — Impacts metabolism of many medications including codeine, tramadol, and certain antidepressants. Poor metabolizers may experience reduced efficacy with codeine while ultrarapid metabolizers face increased toxicity risk.
- CYP2C19 — Affects activation of clopidogrel (blood thinner) and metabolism of many SSRIs. Poor metabolizers may have reduced clopidogrel efficacy with increased cardiovascular event risk.
- SLCO1B1 — Variant carriers have increased risk of simvastatin-induced myopathy (muscle damage), requiring dose adjustment or alternative statin selection.
- HLA Alleles — HLA-B*57:01 carriers risk severe hypersensitivity to abacavir (HIV medication); HLA-B*15:02 carriers have increased risk of severe skin reactions with carbamazepine.
- TPMT/NUDT15 — Affect metabolism of thiopurine drugs used in autoimmune conditions and cancer treatment, with variant carriers requiring significant dose reductions.
The program provides detailed protocols for implementing PGx testing services, including clinical decision support integration, result interpretation guidelines, and payer coverage navigation.
Compliance Curriculum Details
- HIPAA Privacy Rule Implementation — Practical application of Privacy Rule provisions in telehealth, including patient rights, minimum necessary standards, authorized disclosures, Notice of Privacy Practices, and special protections for genetic information.
- Security Rule Safeguards — Comprehensive implementation of administrative safeguards (risk analysis, security officer, training), physical safeguards (workstation security, device controls), and technical safeguards (access controls, audit logs, encryption, transmission security) for telegenetics.
- Business Associate Management — Creating and managing compliant Business Associate Agreements (BAAs) with telehealth platforms, cloud storage providers, billing services, and other vendors handling protected health information.
- Breach Response Protocols — Developing breach detection systems, incident response procedures, documentation requirements, notification timelines, and mitigation strategies aligned with HITECH requirements.
- ONC Cures Act Requirements — Information blocking prohibition and exceptions; patient electronic health information access; API implementation for data exchange; USCDI data element compliance; FHIR-based interoperability standards.
- OSHA Compliance for Telehealth — Remote workstation ergonomics standards; bloodborne pathogen protocols for kit handling; hazard communication requirements; emergency action planning for remote teams; documentation and training requirements.
- Written Policies and Procedures — Developing comprehensive documentation covering all aspects of telegenetics practice, including code of conduct, billing policies, and genetic testing protocols.
- Compliance Officer and Committee — Establishing compliance leadership structure with appropriate authority, reporting mechanisms, and dedicated resources.
- Effective Training and Education — Implementing initial and ongoing compliance education for all staff, with specialized modules for telehealth, genetic testing, and billing functions.
- Communication Channels — Creating accessible reporting systems for compliance concerns, including anonymous options and non-retaliation protections.
- Monitoring and Auditing — Developing systematic review processes for high-risk areas including telehealth documentation, genetic test ordering, and claim submission.
- Consistent Enforcement — Establishing disciplinary standards and incentives to promote compliance culture throughout the organization.
- Prompt Response to Issues — Creating investigation protocols, corrective action procedures, and self-disclosure policies for identified compliance problems.
The program provides comprehensive compliance templates, risk assessment tools, and audit checklists that participants can customize for their specific telegenetics practice model.
Enrollment Process and Program Fees
The TeleMedical Genetics professional program requires a total investment of $1,969, structured to cover all aspects of your comprehensive training experience.
$369 — Registration/Enrollment Fee
Covers application processing, eligibility verification, and personalized track selection to ensure optimal program fit.
$599 — Technology/Platform Fee
Provides access to HIPAA-compliant video conferencing, secure messaging, and practice management platforms for hands-on learning.
$469 — Tuition Fee
Covers core instructional content and specialized modules delivered by industry experts throughout the 24-week program.
$99 — Assessment/Certification Fee
Includes all evaluations and assessments, plus formal credentialing documentation upon successful program completion.
$199 — Materials Fee
Provides comprehensive digital and physical resources, clinical guidelines, and specialty protocols for practice implementation.
$234 — Placement Assistance Fee
Supports job placement assistance, patient acquisition strategies, and business development coaching following program completion.
Flexible Payment Plans
- Option 1: Full payment of $1,969 at enrollment
- Option 2: Split payment with $899 due at enrollment and the remaining balance due at course completion
Quarterly Cohort Schedule
- Spring — Application by Feb 15, Program Dates: Mar 1 – Aug 31
- Summer — Application by May 15, Program Dates: Jun 1 – Nov 30
- Fall — Application by Aug 15, Program Dates: Sep 1 – Feb 28
- Winter — Application by Nov 15, Program Dates: Dec 1 – May 31
- Complete online application at www.Telehealth.school/apply
- Schedule consultation call with admissions team
- Submit documentation and select payment option
- Gain immediate access to orientation materials
Website: www.Telehealth.school
Email: info@telehealth.school
Phone: (848) 233-3332
Day-in-the-Life: Running a Telegenetics Clinic
This sample schedule illustrates the typical flow of a fully operational telegenetics practice, demonstrating how providers balance direct patient care with administrative responsibilities and professional development.
- 7:45 - 8:00 AM: Morning Setup — Complete security check and system login. Review overnight messages, lab alerts, and daily dashboard metrics to prepare for patient encounters.
- 8:00 - 8:10 AM: Daily Huddle — Conduct brief team meeting to review caseload, identify potential escalations, and confirm coverage arrangements for the day.
- 8:10 - 8:30 AM: Pre-visit Preparation — Review scheduled patients' pedigrees, clinical indications, and insurance prerequisites to ensure efficient consultations.
- 8:30 AM - 12:00 PM: New Consultations — Conduct six 30-35 minute initial telegenetics consultations across different service lines (hereditary cancer, pharmacogenomics, prenatal). Complete electronic consent, test selection, and home kit ordering during sessions.
- 12:00 - 12:30 PM: Administrative Break — Quick lunch while managing message inbox and submitting prior authorization requests for ordered genetic tests.
- 12:30 - 2:30 PM: Results Consultations — Deliver test results to three patients in 30-40 minute sessions. Provide summary letters, management templates, and cascade testing information for family members.
- 2:30 - 3:00 PM: Multidisciplinary Conference — Participate in virtual case review board with specialists from oncology, cardiology, and genomics to discuss complex cases.
- 3:00 - 4:00 PM: Documentation and Billing — Complete clinical documentation, finalize billing codes, verify modifiers, and review claims for submission.
- 4:00 - 4:45 PM: Practice Development — Conduct outreach activities including referral liaison calls and educational webinar preparation to build practice visibility.
- 4:45 - 5:30 PM: Professional Development — Dedicate time to learning activities including variant curation, journal review, and standard operating procedure updates.
The program provides detailed workflow templates, scheduling optimization tools, and efficiency strategies to help participants maximize productivity while maintaining quality care and work-life balance in telegenetics practice.
Teaching Case Studies
Complex Clinical Scenarios in Telegenetics Practice — The program incorporates realistic case studies that illustrate common challenges in telegenetics practice. Each case focuses on specific learning objectives related to both clinical management and telehealth implementation.
Patient: 42-year-old with triple-negative breast cancer; panel testing returns variant of uncertain significance.
Learning Objectives: Applying evidence-based management without VUS-driven surgical decisions; developing cascade testing strategies; implementing variant reclassification monitoring; creating insurer-friendly documentation.
Patient: 37-year-old with MMR-deficient colon tumor; germline PMS2 pathogenic variant identified.
Learning Objectives: Creating effective family communication letters; developing appropriate screening protocols; implementing interstate cascade testing workflows; mastering complex billing scenarios for genetic counseling and testing.
Patient: 22-year-old athlete with abnormal echocardiogram; MYBPC3 variant identified.
Learning Objectives: Constructing family screening algorithms; developing remote phenotype monitoring plans; creating counseling scripts for athletic participation guidance.
Patient: 45-year-old with LDL 230 mg/dL; LDLR variant identified with concurrent PGx testing for SLCO1B1.
Learning Objectives: Implementing cascade screening kit distribution; navigating insurance prior authorization; providing integrated risk management.
Patient: 34-year-old with multiple SSRI failures; identified as CYP2C19 ultrarapid metabolizer.
Learning Objectives: Configuring clinical decision support alerts; coordinating medication changes with prescribers; tracking outcomes for quality improvement.
Patient: 31-year-old at 12 weeks gestation with positive non-invasive prenatal screening.
Learning Objectives: Providing balanced counseling on screening vs diagnostic testing; coordinating invasive procedures; delivering non-directive support; documenting time-based billing.
Additional cases cover pediatric neurodevelopmental delay, hereditary paraganglioma, adult-onset mitochondrial disease, and precision oncology scenarios. Each case includes complete documentation templates, billing examples, and telehealth implementation guidance that participants can adapt for their practice.
Financial Potential Model
This illustrative model provides a realistic perspective on the potential financial outcomes of a telegenetics practice. Actual results will vary based on numerous factors including geographic location, payer mix, and practice efficiency.
$0.00 — $600,000.00 — $1,200,000.00 — $1,800,000.00 (Weekly, Monthly, Quarterly, Annual) | Minimum ($95/visit) — Maximum ($700/visit)
Key Financial Considerations — Revenue Drivers
- Visit Volume: Target of 200 completed encounters monthly
- Service Mix: Range from simple follow-ups ($95) to comprehensive new evaluations ($700)
- Payer Contracts: Negotiated rates with insurers significantly impact revenue
- Geographic Reach: Multi-state licensure expands potential patient base
- Test Selection: Appropriate ordering patterns maximize clinical value and reimbursement
Expense Considerations
- 35-45% Staffing — Provider compensation, administrative support, genetic counseling assistants
- 10-15% Technology — Telehealth platform, EHR, laboratory interfaces, secure communications
- 5-10% Operations — Licensing, malpractice insurance, test kits, billing services
Important Disclaimer: Revenue varies widely based on geography, licensure, credentialing, payer contracts, case mix, denials, and compliance factors. The figures presented represent potential outcomes but are not guarantees of earnings. Individual results will depend on multiple variables including your personal performance and market conditions.
The program provides detailed financial planning tools, including pro forma templates, breakeven calculators, and payer mix optimization strategies to help participants develop realistic business projections for their specific telegenetics practice model.
Career Pathway and Key References
Upon program completion, graduates are equipped with practical deliverables ready for immediate implementation:
- Practice Blueprint — Comprehensive business plan including service definition, market analysis, operational framework, and financial projections tailored to your specific telegenetics focus.
- Compliance Documentation — Complete set of policies, procedures, forms, and risk assessment tools meeting HIPAA, HITECH, OIG, and other regulatory requirements for telegenetics practice.
- Marketing Plan — Strategic marketing framework including target audience definition, messaging development, channel selection, and campaign calendar for practice growth.
- Practice Implementation Tools — Mock audit protocols, payer enrollment workbooks, contracting templates, and vendor evaluation matrices to streamline practice launch.
Career Support Services — The program includes job search coaching, portfolio review, and employer introductions through the placement assistance component. While employment is not guaranteed, these resources enhance your marketability and help you effectively showcase your specialized skills.
Practice Ownership Track — For those pursuing independent practice, the program provides entity formation guides, contract templates, payer enrollment checklists, and vetted vendor referrals to facilitate practice establishment.
The program curriculum aligns with authoritative resources including:
- ACMG/AMP variant classification standards
- NSGC practice guidelines and telehealth statements
- NCCN Genetic/Familial Risk Assessment guidelines
- AHA/ACC/HRS cardiac genetics statements
- ACOG/SMFM prenatal genetics bulletins
- CPIC pharmacogenomics guidelines
Key Reference Resources
- Clinical Resources — ClinVar, gnomAD, OMIM, and HGMD databases for variant interpretation; CPIC guidelines for pharmacogenomics (cpicpgx.org); MotherToBaby teratogen information services
- Regulatory Guidance — HHS/OCR HIPAA resources (hhs.gov/hipaa); ONC Cures Act materials (healthit.gov); OIG Compliance Program Guidance (oig.hhs.gov); OSHA standards (osha.gov)
- Quality Standards — CLIA regulations and CAP accreditation checklists; FDA frameworks for diagnostic testing; ISO/IEC 27001 security management; SAMHSA/42 CFR Part 2 sensitive data guidelines
The program provides a comprehensive digital library with organized access to these resources, enabling graduates to maintain current knowledge and practice standards after program completion.
What You Build During the Course
Comprehensive Practice Development Assets — Throughout the 24-week program, participants progressively develop the complete toolkit needed to launch and operate a successful telegenetics practice. These deliverables provide immediate value upon program completion.
Comprehensive set of standard operating procedures covering privacy, security, testing protocols, genetic counseling workflows, and billing processes, all customized for telehealth delivery.
Detailed security risk analysis template, vulnerability assessment tools, and mitigation planning matrix aligned with HIPAA Security Rule requirements for telegenetics practice.
Technical architecture diagram with EHR, telehealth platform, and laboratory system connections, including FHIR endpoint specifications and data flow documentation.
Comprehensive pricing structure, payer contracting templates, revenue cycle workflows, and financial projection models tailored to telegenetics services.
Complete set of patient-facing materials including electronic consent forms, pre-visit questionnaires, pedigree collection tools, results letters, and cascade testing protocols.
Interactive dashboard for tracking key performance indicators including access metrics, turnaround times, patient satisfaction scores, and revenue cycle performance.
The program culminates in a comprehensive capstone project that synthesizes all course elements into a cohesive, executable plan for launching your TeleMedical Genetics practice. This detailed blueprint includes implementation timelines, resource requirements, staffing models, technology specifications, and marketing strategies tailored to your specific practice vision.
With these deliverables in hand, graduates are positioned to efficiently implement their telegenetics service, whether as an independent practice, a service line within an existing organization, or a specialized consulting offering.